Submit Deal

Announced

17 Jul 2020

Completed

17 Jul 2020

BioAtla completed a $72m Series D funding round.

Synopsis

Soleus Capital, HBM Healthcare, Cormorant Asset, Farallon Capital, Pappas Capital, Janus Henderson, Boxer Capital and Pfizer Ventures invested $72m Series D funding round in BioAtla, a biological service company.

Principals

target

BIOATLA

bidder

Soleus Capital

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (6)

josh milgrim

Partner at Dechert

Lawyer

target

Deals

£ 29.01 B

Total Value

carly robinson

Associate at Dechert

Lawyer

target

Deals

£ 208 M

Total Value

jay m. short

Founder and CEO at BIOATLA

Manager

target

Deal

£ 56 M

Total Value

tiffany pan

Associate at Dechert

Lawyer

target

Deals

£ 762 M

Total Value

john stanley

Associate at Dechert

Lawyer

target

Deals

£ 56 M

Total Value

david schulman

Partner at Dechert

Lawyer

target

Deals

£ 56 M

Total Value

Bidder Team (6)

steve musumeci

COO at SOLEUS CAPITAL

Investor

bidder

Deals

£ 384 M

Total Value

richard weil

CEO at JANUS HENDERSON INVESTORS

Investor

bidder

Deals

£ 38.88 B

Total Value

bihua chen

Portfolio Manager at CORMORANT ASSET MANAGEMENT

Investor

bidder

Deals

£ 5.19 B

Total Value

tom mathers

CEO at PAPPAS CAPITAL

Investor

bidder

Deal

£ 56 M

Total Value

andreas wicki

CEO at HBM BIOVENTURES AG

Investor

bidder

Deals

£ 2.80 B

Total Value

aaron davis

CEO at BOXER CAPITAL

Manager

bidder

Deals

£ 2.08 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy